http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2567887-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d3448498682eaffa7c1c86a123c5619 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate | 2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6baa4c953923f6fda9a923352c87ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_370bf21c8041e1ef597fa0f271e6c0da |
publicationDate | 2005-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2567887-A1 |
titleOfInvention | Method for screening and compositions for treating cancers |
abstract | The invention relates to compositions and methods for the treatment of proliferative diseases, especially cancers. It is based on the identification of particular properties of TReP-132 in the control of cell cycle and in the control of cell proliferation. This protein behaves like a tumor suppressor and therefore constitutes a preferred target for the development of therapeutic strategies effective. The invention relates to compositions, uses and methods identification of compounds capable of modulating the activity of this protein, and usable for the treatment of various proliferative pathologies, in especially in humans. |
priorityDate | 2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1447.